Key outcomes (demographics, baseline clinical status, complications, early outcomes, quality of life outcomes)_ NYHA-New York heart Association; INTERMACS-Interagency Registry for Mechanically Assisted Circulatory Support; COPD-Chronic Obstructive Pulmonary Disease; QoL-Quality of Life_
| Variable | Value |
|---|---|
| Demographics | |
| Age, years (mean ± SD) | 47.2 ± 12.3 |
| Male sex, n (%) | 11 (84.6) |
| Implant strategy – Bridge-to-transplant, n (%) | 10 (76.9) |
| Implant strategy – Destination therapy, n (%) | 3 (23.1) |
| Baseline clinical status | |
| NYHA class IV, n (%) | 9 (69.2) |
| INTERMACS I–II, n (%) | 2 (15.4) |
| INTERMACS III–IV, n (%) | 3 (23.1) |
| INTERMACS V, n (%) | 8 (61.5) |
| EuroSCORE II low risk (<4%), n (%) | 2 (15.4) |
| EuroSCORE II intermediate risk (4–8%), n (%) | 7 (53.8) |
| EuroSCORE II high risk (>8%), n (%) | 4 (30.8) |
| Postoperative complications | |
| Perioperative bleeding, n (%) | 8 (61.5) |
| Right ventricular failure, n (%) | 3 (23.1) |
| Pneumonia, n (%) | 3 (23.1) |
| Ischemic stroke, n (%) | 1 (7.7) |
| Gastrointestinal bleeding, n (%) | 1 (7.7) |
| Early outcomes | |
| Early mortality (≤45 days), n (%) | 3 (23.1) |
| Survivors at follow-up, n (%) | 10 (76.9) |
| Quality of life outcomes | |
| Reported overall QoL improvement, n | 10 |
| QoL rated good or excellent, n | 7 |
| Independent ambulation regained, n | 10 |
| Resumed regular social interactions, n | 7 |
| Early postoperative psychological distress, n | 6 |
| Regular physical activity (>3 days/week), n | 9 |
| Sleep disturbances early post-implant, n | 7 |
| Transient suicidal ideation post-implant, n | 3 |
| Reported confidence in device management, n | 9 |
| Local driveline infection/trauma, n | 5 |